Pharmacovigilance, Drug Safety and Risk Management 2015

Topics

• The PSUR format, with case studies of its use and challenges
• The benefits and challenges behind outsourcing Pharmacovigilance practices
• The importance of maintaining good PV practices
• The importance of a centralised drug safety database
• The EU’s harmonization initiatives through MedDRA and Eudravigilance
• Causality assessment
• Routine reporting mechanisms and the drive towards consumer technology

Who should Attend

Academics, researchers, pharmaceutical companies and others involved in drug safety and risk management.